Introduction
Approximately 13,500 species of lichen are estimated to inhabit 8% of the earth's surface in various environments, including low temperature, drought, and darkness [1] . To survive in such environments, lichens produce unique secondary metabolite-related compounds that have antimicrobial, antitumoral, immunostimulating, and/or antiviral activities. In addition, they contribute to symbiosis of the mycobiont (fungal partner), photobiont (photosynthetic partner, usually a green algae or cyanobacterium), and non-photosynthetic partner (bacterium). Before 2005, research regarding lichens was focused on lichenicolous fungus [2] and cyanobacteria [3] ; the word 'lichenassociated bacteria' began to appear in the literature, due to the work by Alexandra et al., beginning in 2011 [4] . It has recently been reported that millions of lichen-associated bacteria greatly influence the survival of lichen through various roles such as resistance stress factor, detoxification of metabolites, support for photosynthesis, and nutrient supply [5] . In 2018, Delphine et al. reported using genome analysis to identify a new metabolite from the alpha-proteobacterium strain MOLA1416, a marine type of lichen-associated Proteobacteria [6] . Recent studies of lichenassociated bacteria have been performed to confirm activity and select cultivable bacteria for in-depth genome analysis.
Most research studies regarding lichen-associated bacteria are based on the hypothesis that such bacteria will produce one or more unusual secondary metabolites in the symbiotic relationship. The biosynthesis of secondary metabolites, analyzed by biosynthetic gene cluster, is already well known; this includes multidomain enzymes such as polyketide synthase (PKS) and non-ribosomal peptide synthetase (NRPS) [7] [8] [9] [10] . Although PKS and NRPS comprise most of the metabolite class, knowledge regarding the biological activities of PKS and NRPS genes remains insufficient. Lichen-associated bacteria have been analyzed from diverse environments, including thermal spots [5] , sub-Arctic [11] , and Arctic [12] . Thus far, 465 species of lichen have been identified in Nepal [13] ; nevertheless, there has been no study of the diversity of lichenassociated bacteria or their PKS and NRPS genes. Notably, lichen flora, market potential, and various activities (antioxidant, antimicrobial, and toxicity) were reported regarding lichens [14, 15] . Other lichen-associated bacteria have been reported as examples of bacterial diversity [16] , as sources of novel metabolites [6] , and as samples for genome analysis [17] .
We undertook an extensive study regarding the antimicrobial potential of lichen-associated bacteria. We aimed to identify lichen-associated bacteria from Himalayan lichens and to analyze the genomes of selected bacteria that showed antimicrobial activities with secondary metaboliterelated biosynthetic gene clusters. Based on identification of PKS and NRPS genes using fingerprinting polymerase chain reaction (PCR), we propose the use of lichenassociated bacteria to produce antimicrobial agents. This study also includes draft genome analysis of lichenassociated bacteria to understand the biosynthesis of secondary metabolites.
Materials and Methods

Isolation of Lichen-Associated Bacteria
Two lichens from the Himalayas (Fig. S1 and Table S1 ) were collected (27.718805, 85 .322705), categorized, and identified by morphological analysis. To isolate associated bacteria from lichens, a modified version of the method of Kim et al. [18] was used. The thallus segments of the lichens were spread with sterilized scissors, and 2.0 ml of 0.85% NaCl wash solution was added. The lichens were vortexed for 1 min and the supernatant was discarded; this step was repeated twice. Then, 100-μl aliquots of the washed, broken lichen solution were spread on replicate plates containing MY media (3.0 g malt extract, 3.0 g yeast extract, 10.0 g peptone, 10 .0 g dextrose, and 20.0 g agar, pH 7.2), R2A media (0.5 g proteose peptone, 0.5 g casamino acid, 0.5 g yeast extract, 0.5 g dextrose, 0.5 g soluble starch, 0.3 g sodium pyruvate, 0.3 g dipotassium phosphate, and 0.05 g magnesium sulfate, pH 7.2), or Bennett's media (10.0 g glucose, 1.0 g yeast extract, 2.0 g Bacto-peptone, and 1.0 g beef extract, pH 7.2); the plates were incubated at different temperatures (8, 15, 25 , and 37°C) for 3 to 30 days.
16S rRNA Gene Sequence and Phylogenetic Analysis
All isolated bacteria were identified by 16S rRNA gene sequence analysis. For 16S rRNA analysis, the genomic DNA of each strain was extracted from a 100-μl culture sample from a 15-30 day pure culture of a single colony and centrifuged for 10 min at 10,000 ×g; extraction was performed using the DNeasy Blood and Tissue Kit (Qiagen, Inc., USA). The 16S rRNA was amplified with two universal primers: 518F (5'-CCAGCAGCCGCGGTA ATACG-3') and 800R (5'-TACCAGGGTATCTAATCC-3'). For difficult to analyze sequences, other primers were used: 27F (5'-AGAGTTTGATCMTGGCTCAG-3') and 1492R (5'-TACGGYTAC CTTGTTACGACTT-3'). Sequencing was performed by Genotech Ltd. (Korea); the results were compared with the GenBank database using BLAST to identify the most similar sequences. Closest relative strains were also identified using EzBioCloud (ChunLab, Inc., Korea), and the species of the isolates were predicted. The sequences were pairwise aligned, and phylogenetic analysis was performed using a modified version of the method described by Kimura et al. [19] . A phylogenetic tree was inferred using the neighbor-joining method in MEGA X [20] .
Extraction of Isolated Strains and Disk Diffusion Assay
For the antimicrobial assay, each of the 49 lichen-associated bacteria isolates was cultured in 200 ml liquid medium in conditions identical to those in which it was isolated. A double volume of analytical-grade ethyl acetate (Daejung, Korea) was added into the grown culture fluid, and shaken using a funnel at room temperature for 2 h for extraction. The solvent layer was concentrated using a rotary evaporator (EYELA A-1000S, Tokyo Rikakikai Co., Japan), and each extract was dissolved in 2.0 ml ethyl acetate. The antimicrobial activities of all extracts obtained from the 49 isolated strains were investigated using 16 multidrugresistant microorganisms, including anaerobic and aerobic bacteria, by the disc diffusion method. Anaerobic bacteria were Staphylococcus aureus (KCTC1927), Streptococcus mutans (KCTC3065), Streptococcus sanguinis (KCTC3284), Streptococcus sobrinus (KCTC3308), Streptococcus cricetid (KCTC3640), Streptococcus ratti (KCTC3655), Aggregatibacter actinomycetemconitans (KCTC3698), Streptococcus anginosus (KCTC3983), Actinomyces viscosus (KCTC5531), and Actinomyces israelii (KCTC9054); aerobic bacteria were Bacillus subtilis (KCTC1918), Staphylococcus aureus (KCTC1928), Micrococcus luteus (KCTC1915), Escherichia coli (KCTC2441), Pseudomonas aeruginosa (KCTC1637), and Enterobacter cloacae (KCTC1685). The bacteria were purchased from the Korea Collection for Type Culture and Korea Research Institute of Bioscience and Biotechnology (Korea). All microorganisms were grown in Luria-Bertani (MBcell Ltd., Korea) or tryptic soy (Becton Dickinson Co., USA) or brain-heart infusion broth (Becton Dickinson Co.) under the appropriate conditions. The paper disk diffusion test was performed in accordance with the method of Bauer et al., with some modifications [21] . The growth of each of the 16 multidrugresistant microorganisms was standardized to 0.5 McFarland and spread with a swab. Each extract was added to a paper disk (6-mm diameter, Advantec Co., Japan) and the disks were transferred onto plates inoculated with the multidrug-resistant bacterial strains. Disks containing ethyl acetate were used as negative controls. All inoculated culture plates were incubated at 37°C, and the inhibition zones of bacterial growth were measured approximately 9 h later. All analyses were performed in triplicate, and the experimental values are reported as means ± standard deviation.
Fingerprinting of PKS and NRPS Genes
In the fingerprinting experiment, eight sets of degenerate primers (Table 1) targeting genes encoding the ketoacyl synthase (KS) domains of type I PKS and type II PKS (i.e., PKS-1 and PSK-2) and the adenylation domain of NRPS were used to screen the biosynthetic potentials of the isolates [9, 10, [21] [22] [23] [24] . PCR was performed as follows: the 20 μl reaction sample contained 10 μl Noble premix (Noble Bio Inc., Korea), 4 μl total DNA, 4 μl distilled water, and 1 μl of each primer. Amplification comprised denaturation at 95°C for 1 min, annealing at 50-68°C for 1 min, and extension at 72°C for 2 min. The sizes of the PCR products were 600-1,000 bp for PKS and NRPS genes; these were purified by electrophoresis in a 1% (wt/vol) agarose gel. Purified PCR products were ligated into pMD20-T vectors (Takara Inc., Japan), and transformed into competent E. coli XLI-blue. Positive recombinants were screened on 5-bromo-4-chloro-3-indoly-β-D-galactopyranoside (X-Gal), isopropyl-β-D-thiogalactopyranoside, and ampicillin indicator plates by color-based recombinant selection. Plasmid purification was performed using an isolation kit (GeneAll Co., Korea) and sequence analysis was carried out by Genotech Ltd. The BLASTX algorithm with default parameters was used to identify database entries related to the isolated sequences. A phylogenetic tree was generated based on the PKS and NRPS fingerprinting results; it was constructed using multiple sequence alignment tools, the Mega package, and the neighbor-joining method.
Draft Genome Sequencing of NP160
We selected lichen-associated bacteria with the highest probability to be used as a new antimicrobial agent. Genomic DNA was extracted from Streptomyces sp. NP160 using a QIAamp DNA Mini Kit (Qiagen, Inc.), and the quantity and purity were determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, USA) [25] . Sequencing was performed using an Illumina MiSeq system with a 300 bp paired-end library. De novo assembly of genome sequences was performed using Celera Assembler software (Ver. 8.3) with Illumina short reads. Prior to assembly, *Annealing temperature was modified based on the results of preliminary experiments for this study.
Illumina reads were trimmed using FASTX-Toolkit software (http://hannonlab.cshl.edu/fastx_toolkit) with parameters -t 20, -I 70, and -Q 33; a paired sequence was then selected from trimmed Illumina reads. Coding DNA sequences (CDSs) were predicted and annotated using the National Center for Biotechnology Information (NCBI) Prokaryotic Genome Annotation Pipeline and the Rapid Annotation using the Sub-system Technology server [26] . The numbers and types of secondary metabolites present in microbial genomes were determined using antiSMASH software (version 4.2) [27] . For the analysis of antiSMASH results, each gene was predicted using BLASTX and compared with known gene clusters.
Results and Discussion
Identification of Lichen-Associated Bacteria and Phylogenetic Analysis We isolated 185 lichen-associated bacteria from the rarely studied Himalayan region. Based on their color and morphology when grown on media, we selected 49 isolates for further analysis (Table S2 ). The isolated bacteria ratios were balanced (Fig. 1) , which contrasts with the findings of prior studies in which most such bacteria were classified as Alphaproteobacteria [28] . Forty-nine of the isolates underwent phylogenetic analysis. Based on BLAST analysis of 16S rRNA gene sequences, we found that the isolates were divided into three dominant groups: 17 species of Actinobacteria, 19 species of Firmicutes, and 13 species of Proteobacteria (Fig. 1A) . The 17 species of Actinobacteria were classified as Curtobacterium spp., Leifsonia spp., Streptomyces spp., and Rhodococcus spp. Furthermore, a phylogenetic tree constructed using the neighbor-joining method enabled us to identify isolates at the genus level with over 98% identity (Fig. 1B) . According to Suzuki et al., there have been some studies of lichen-associated bacteria from various lichens, and secondary metabolites of Amycolatopsis have been reported [29] .
Antimicrobial Properties of Lichen-Associated Bacteria
To evaluate the antimicrobial potentials of the isolated bacteria, a paper disk diffusion test was performed. In this test, our extracts showed similar antimicrobial strengths, with zone of inhibition diameters of 6-20 mm against both anaerobic and aerobic bacteria. As shown in Table 2 , most strains had no antimicrobial activity or narrow antimicrobial activity; however, 12 isolates showed inhibitory antimicrobial activity against both Gram-negative and Gram-positive bacteria. In particular, strains NP088, NP131, NP132, NP134, and NP160 had the strongest inhibitory activity, which suggested that they produced antimicrobial agents.
These isolates were classified as Bacillus, Methylobacterium, and Streptomyces. Strain NP160 showed the most potent antimicrobial activity, with a zone of inhibition diameter of 22.89 ± 1.07 mm against Streptococcus anginosus, which causes pyogenic liver abscess. In our antimicrobial activity assays, each bacterial species exhibited the strongest antimicrobial resistance known.
Lichen-associated bacteria have been isolated from a variety of lichen. Each bacterium plays a role in symbiosis and has potential for biotechnological applications; these primarily include nitrogen fixation and phosphate solubilization, which can promote plant growth [30] . Only Kim et al. reported the antimicrobial activity of lichenassociated bacteria; these organisms showed zone of inhibition diameters of 8-12 mm [18] . Our isolates showed stronger inhibitory antimicrobial activity and were predicted to produce antimicrobial agents. We presume that each lichen-associated bacterial species has a unique role within the lichen. Therefore, we further assessed the antimicrobial activity and corresponding biosynthetic analysis using fingerprinting of PKS and NRPS genes.
Fingerprinting of PKS and NRPS Genes
Many intriguing secondary metabolites are biosynthesized by the PKS, NRPS, and PKS-NRPS hybrid systems. To assess the biosynthetic potentials of lichen-associated bacteria regarding PKS and NRPS systems, we evaluated each of the 49 isolated strains by amplifying PKS (type I and type II) and NRPS genes with eight sets of diverse primers. The results revealed 148 PCR products. Only the products of our desired size were refined and analyzed, and the results were obtained for 69 samples. We confirmed the identities of PKS and NRPS genes by BLASTX comparison with those in the GenBank database. Most PKS genes showed high similarities of 40-100%. We identified 19 acyltransferase domain genes, nine adenylation-related domain genes, five beta-ketoacyl domain genes, 13 fatty acid-related PKS genes and four hybrid PKS-NRPS genes (Table S3) . PKS fingerprinting results revealed that most strains had more than one PKS-NRPS-related gene. Most fingerprinting genes were involved in bacillaene biosynthesis (e.g., PksC, PksF, PksG, PksH, PksI, PksJ, PksL, PksM, PksN, and PksR) [31] . Strain NP160 had the greatest number of PKS and NRPS genes without any bands indicative of nonspecific amplification (Fig. S2) ; it also demonstrated the strongest antimicrobial activity. Fingerprinting showed that NP160 had six types of PKS-and NRPS-related genes. Although the primers were constructed on the basis of PKS and NRPS domains, it was difficult to determine whether enzyme function was consistent among the isolates. Therefore, we aimed to analyze the draft genome in detail; we selected strain NP160, which was predicted to produce several secondary products. 
Draft Genome Analysis of Streptomyces sp. NP160
In previous studies, some lichen-associated bacteria were shown to produce secondary metabolites, and corresponding genomic analyses were performed [32] . Researchers have found much of interest in the genomes and secondary metabolites of lichen-associated bacteria. Among the 49 lichen-associated bacteria, we found many isolates that could produce various substances. Although many researchers have reported on lichen-associated bacteria, this study describes secondary metabolite substanceproducing strains and fatty acid synthesis-related PKS genes. Strain NP160 had robust expression of six types of PKS and NRPS genes, as well as strong antimicrobial activity. PKS fingerprinting methodology cannot readily be 
used to classify gene clusters of antimicrobial agents; therefore, we assembled a draft genome of strain NP160 to identify biosynthetic genes related to secondary metabolite gene clusters. The draft genome sequence had a size of 4,774,418 bp with a G+C content of 50.01%, and generated a total of 2,455,256 reads. Predicted gene sequences were translated and searched against the NCBI non-redundant, Clusters of Orthologous Groups, and Kyoto Encyclopedia of Genes and Genomes databases. A total of 4,319 CDSs were predicted; the coding region comprised 89.1% of the genome. In addition, 3 rRNAs and 44 tRNAs were predicted, and genome assembly resulted in 186 contigs, as shown in Fig. 2 . Based on the draft genome results, strain NP160 was classified as Streptomyces mauvecolor. Thus far, this species has only one strain; the anti-fungal activity of S. mauvecolor BU16 was previously described [33] . Importantly, our analysis demonstrated biosynthesis of secondary metabolites in a unique bacterial strain, S. sp. NP160.
Predicted Biosynthetic Gene Cluster for Secondary Metabolites in S. sp. NP160 S. sp. NP160 was assessed for the presence of secondary metabolite gene clusters using antiSMASH, based on draft genome information. The results showed that S. sp. NP160 had 46 secondary metabolite gene clusters; 19 of these gene clusters were similar to previously described secondary metabolite biosynthetic gene clusters, including sioxanthin, meiligmycin, lomaiviticin, divergolide, lasalocid, incedinine, GE81112, 5'-hydroxystreptomycin, furaquinocin, ravidomycin, calicheamicin, paromomycin, surfactin, teicoplanin, chlortetracycline, chlorizidine A, and alkylresorcinol. These gene clusters demonstrated diverse similarities of 5-100%, as shown in Table 3 . There were several types of clusters, such as terpene, saccharide, fatty acid, and PKS type III; these contained PKS-related clusters (e.g., divergolide, lasalocid, and meridamycin), but showed low similarity with well-known gene clusters. Therefore, we chose to predict four types of clusters that putatively encoded known pathways for the production of sioxanthin, furaquinocin A, chlorizidine A, and alkylresorcinol. Although most clusters displayed low levels of similarity with well-known clusters, cluster 46 of S. sp. NP160 had 100% similarity with the alkylresorcinol biosynthetic gene cluster (Fig. 3) . Alkylresorcinol is classified as a resorcinolic lipid, which can help prevent cells from becoming cancerous. Nearly all gene clusters had PKS-related genes, such as acyl carrier protein and ketoacyl transferase; cluster 2, which had a terpene gene cluster, was an exception. Based on these results, our PKS fingerprinting data matched genome analysis data in that both showed several genes related to PKS, such as acyltransferase and acyl carrier protein (Table S3 and Fig. 3 ).
In conclusion, most lichens produce unique secondary metabolites and are known to contain multiple chemical constituents; these include mono-substituted phenyl rings, terpenes, fatty acids, and polysaccharides, with antitumor, antimicrobial, anti-inflammatory, antioxidant, and antithrombosis activities. In particular, lichens of Ramalina sp. have been reported to exhibit antioxidant activities due to the presence of salazinic acid and usnic acid (Table S1) . Although most bioactive compounds in lichens are produced by fungi, lichen-associated bacteria also produce bioactive compounds. Streptomyces species can perform biosynthesis of secondary metabolites [34] . It was recently published that lichen-associated bacteria can produce a phthalazinone derivative [29] . Therefore, we hypothesized that our strain could produce secondary metabolites or other unique metabolites. Based on antimicrobial activity and PKS fingerprinting results, we selected a strain for draft genome analysis, and identified putative secondary metaboliterelated biosynthetic gene clusters. S. sp. NP160 had 30 unknown gene clusters that were predicted to have antimicrobial activity. The biosynthetic gene cluster results showed low similarity with those of known clusters; only two S. sp. NP160 biosynthetic gene clusters showed similarity > 60% with known clusters. We expect that new secondary metabolites can be isolated from S. sp. NP160. In addition, strain NP160 was predicted to contain meiligmycin and alkylresorcinol, which have been reported to exhibit antimicrobial activity. Therefore, we presume that NP160 can produce an alkylresorcinol derivative with antimicrobial activity. In the present study, we assessed antimicrobial activity and performed PKS fingerprinting of cultivable lichen-associated bacteria from the Himalayas to identify potential new antimicrobial agents. Our results can aid in the investigation of novel antimicrobial agents and provide a basis for genome analysis of lichen-associated bacteria; moreover, the results increase the available knowledge regarding the relationship between lichens and bacteria.
Nucleotide Sequence Accession Numbers
The draft genome information of Streptomyces sp. NP160 was deposited in GenBank under the accession number VDMJ00000000. 
